Final results for the year to March are in line with the April trading update, which had been well ahead of expectations in profit and cashflow: with some customer orders postponed beyond year end, revenue of £10.4m had been 6% behind expectations while adjusted PBT (£0.8m) and free cashflow (£1.0m) were respectively 499% and 227% ahead. Strong cost control still permitted £2.8m (FY19: £2.9m) of R&D, leading to the continuing development of the global large e
02 Jun 2020
Intercede - Priming for strong growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Intercede - Priming for strong growth
Intercede Group plc (IGP:LON) | 110 -2.2 (-1.8%) | Mkt Cap: 63.8m
- Published:
02 Jun 2020 -
Author:
Andrew Darley | Cavendish Research -
Pages:
16
Final results for the year to March are in line with the April trading update, which had been well ahead of expectations in profit and cashflow: with some customer orders postponed beyond year end, revenue of £10.4m had been 6% behind expectations while adjusted PBT (£0.8m) and free cashflow (£1.0m) were respectively 499% and 227% ahead. Strong cost control still permitted £2.8m (FY19: £2.9m) of R&D, leading to the continuing development of the global large e